Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer

Published:2020-07-22 Issue:17 Volume:24 Page:9705-9711
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Xu Chunhua¹²^ORCID,Yuan Qi¹²,Hu Huidi³,Wang Wei¹²,Zhang Qian¹²,Li Li¹²,Wang Jiwang⁴,Yang Rusong⁵

Affiliation:

1. Department of Respiratory Medicine The Affiliated Brain Hospital of Nanjing Medical University Nanjing China

2. Clinical Center of Nanjing Respiratory Diseases and Imaging Nanjing China

3. Department of Pathology The Affiliated Brain Hospital of Nanjing Medical University Nanjing China

4. Department of Respiratory Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing China

5. Department of Thoracic Surgery The Affiliated Brain Hospital of Nanjing Medical University Nanjing China

Funder

Major Program of Nanjing Medical Science and Technique Development Foundation

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.15518

Reference26 articles.

1. Cancer statistics, 2018

2. Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer

3. Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer

4. Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer

5. Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of antitumor potential of an anti-glypican-1 monoclonal antibody in preclinical lung cancer models reveals a distinct mechanism of action;Exploration of Targeted Anti-tumor Therapy;2024-06-17

2. The Diagnostic and Prognostic Value of the Combination of Tumor M2-Pyruvate Kinase, Carcinoembryonic Antigen, and Cytokeratin 19 Fragment in Non-Small Cell Lung Cancer;Technology in Cancer Research & Treatment;2024-01

3. Expression and prognostic value of Cripto‐1 in early non‐small cell lung cancer;The Clinical Respiratory Journal;2023-08

4. Understanding the role of Cripto-1 in cancer progression and therapeutic strategies;Clinical and Translational Oncology;2022-12-01

5. Identification of risk variants related to malignant tumors in children with birth defects by whole genome sequencing;Biomarker Research;2022-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3